AI-081 Clinical Trials (2026): 1 Studies for Advanced Solid Tumor
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 AI-081 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumor) and 387 total planned enrollment. 1 AI-081 clinical trial is actively recruiting at 18 U.S. sites across 13 states. Most recent activity: NCT06635785 (Dec 2027).
Where to Participate: All AI-081 Trial Sites in the U.S. (18 sites across 13 states)
Every actively recruiting AI-081trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | University of Alabama at Birmingham | Birmingham35233 | NCT06635785 | Map |
| AR | Highlands Oncology Group | Springdale72762 | NCT06635785 | Map |
| DC | MedStar Georgetown University Hospital | Washington D.C.20007 | NCT06635785 | Map |
| FL | University of Florida UF Health Cancer Center | Gainesville32610 | NCT06635785 | Map |
| FL | Memorial Healthcare System | Hollywood33021 | NCT06635785 | Map |
| FL | Ocala Oncology Center PL DBA Florida Cancer Affiliates | Ocala34474 | NCT06635785 | Map |
| FL | AdventHealth Cancer Institute | Orlando32804 | NCT06635785 | Map |
| IL | Northwestern University | Chicago60611 | NCT06635785 | Map |
| KY | Norton Cancer Center | Louisville40202 | NCT06635785 | Map |
| MA | Dana-Farber Cancer Institute | Boston02215 | NCT06635785 | Map |
| MI | University of Michigan Rogel Cancer Center | Ann Arbor48109 | NCT06635785 | Map |
| MI | Henry Ford Health | Detroit48202 | NCT06635785 | Map |
| NC | University of North Carolina at Chapel Hill Cancer Center | Chapel Hill27599 | NCT06635785 | Map |
| NC | Novant Health Cancer Institute | Winston-Salem27103 | NCT06635785 | Map |
| OH | The Ohio State University James Cancer Center | Columbus43210 | NCT06635785 | Map |
| SC | Prisma Health | Greenville29605 | NCT06635785 | Map |
| TX | MD Anderson Cancer Center | Houston77030 | NCT06635785 | Map |
| UT | University of Utah Huntsman Cancer Institute | Salt Lake City84112 | NCT06635785 | Map |
AI-081 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1/P2 | 1 | 1 |
Recruiting AI-081 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06635785 | BiPAVE-001Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors | P1/P2 | Advanced Solid Tumor | 387 | Mar 2025 |
All AI-081 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06635785 | BiPAVE-001 | Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors | P1/P2 | recruiting | 387 | OncoC4, Inc. | Mar 2025 |
AI-081 clinical trials: frequently asked questions
- How many AI-081 clinical trials are there?
- 1 AI-081 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are AI-081 clinical trials recruiting in 2026?
- Yes — 1 AI-081 trial is actively recruiting in 2026, with 18 U.S. sites across 13 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is AI-081 being studied for?
- AI-081 is being studied for Advanced Solid Tumor. The trials are grouped by indication on this page.
- Who sponsors AI-081 clinical trials?
- The lead sponsor across the most AI-081 trials is OncoC4, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AI-081as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: